Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Riederer, M., Erwa, W., Zimmermann, R., Frank, S
In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group
Note: For complete details, please review product monographs at and regularly review current Health Canada advisories, warnings and recalls at: for the most up to date information.) Table 4: Treatment of B 12 deficiency (adapted from Means 2021) 27 Note: Intranasal administration is generally not used
Patients mith have long asymptomatic (pain-free) periods between episodes that last for months or years
Upgrade your skillset today with our team of experts
The peptide is primarily studied for targeted lipolysis the breakdown of stored triglycerides as well as adipose tissue metabolism, body composition endpoints, and more recently chondrocyte and cartilage repair models
